Early Use of Levosimendan Compared to Usual Care in Advanced Chronic Heart Failure (ACHF).
Phase of Trial: Phase III
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Levosimendan (Primary) ; Furosemide
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms ELEVATE
- 07 Jun 2017 Biomarkers information updated
- 07 Apr 2017 Status changed from suspended to discontinued.
- 28 Mar 2017 Planned End Date changed from 1 Dec 2015 to 1 Mar 2017.